153 related articles for article (PubMed ID: 28274792)
1. Prospective study of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced renal cell cancer.
Lin M; Xu K; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L
Immunol Lett; 2017 Apr; 184():98-104. PubMed ID: 28274792
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced non-small cell lung cancer.
Lin M; Liang SZ; Wang XH; Liang YQ; Zhang MJ; Niu LZ; Chen JB; Li HB; Xu KC
Immunol Res; 2017 Aug; 65(4):880-887. PubMed ID: 28508945
[TBL] [Abstract][Full Text] [Related]
3. Cryoablation combined with allogenic natural killer cell immunotherapy improves the curative effect in patients with advanced hepatocellular cancer.
Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
Oncotarget; 2017 Oct; 8(47):81967-81977. PubMed ID: 29137237
[TBL] [Abstract][Full Text] [Related]
4. [Effect of transcatheter renal arterial embolization combined with cryoablation on regulatory CD4+ CD25+ T lymphocytes in the peripheral blood of patients with advanced renal carcinoma].
Liu CF; Guo Z; Si TG; Xing WG; Liu F; Xing JZ
Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(13):902-5. PubMed ID: 20646510
[TBL] [Abstract][Full Text] [Related]
5. Effect of transcatheter renal arterial embolization combined with cryoablation on regulatory CD4+CD25+ T lymphocytes in the peripheral blood of patients with advanced renal carcinoma.
Li Y; Guo Z; Liu CF; Xing WG; Si TG; Liu F; Guo XY; Xing JZ
Cryobiology; 2012 Aug; 65(1):56-9. PubMed ID: 22521783
[TBL] [Abstract][Full Text] [Related]
6. Short-term clinical efficacy of percutaneous irreversible electroporation combined with allogeneic natural killer cell for treating metastatic pancreatic cancer.
Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
Immunol Lett; 2017 Jun; 186():20-27. PubMed ID: 28392199
[TBL] [Abstract][Full Text] [Related]
7. Prospective analysis of the safety and efficacy of percutaneous cryoablation for pT1NxMx biopsy-proven renal cell carcinoma.
Rodriguez R; Cizman Z; Hong K; Koliatsos A; Georgiades C
Cardiovasc Intervent Radiol; 2011 Jun; 34(3):573-8. PubMed ID: 20628879
[TBL] [Abstract][Full Text] [Related]
8. Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial.
Arai S; Meagher R; Swearingen M; Myint H; Rich E; Martinson J; Klingemann H
Cytotherapy; 2008; 10(6):625-32. PubMed ID: 18836917
[TBL] [Abstract][Full Text] [Related]
9. [Clinical efficacy of transcatheter renal arterial embolization plus cryoablation for medium and advanced renal carcinomas].
Liu F; Guo Z; Xing WG; Si TG; Liu CF
Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(29):2023-5. PubMed ID: 22093927
[TBL] [Abstract][Full Text] [Related]
10. Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome.
Alnaggar M; Lin M; Mesmar A; Liang S; Qaid A; Xu K; Chen J; Niu L; Yin Z
Cell Physiol Biochem; 2018; 48(5):1882-1893. PubMed ID: 30092590
[TBL] [Abstract][Full Text] [Related]
11. MDSC-decreasing chemotherapy increases the efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma and pancreatic cancer.
Wang Z; Liu Y; Zhang Y; Shang Y; Gao Q
Oncotarget; 2016 Jan; 7(4):4760-9. PubMed ID: 26716894
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
[TBL] [Abstract][Full Text] [Related]
13. Tumor cryoablation in combination with natural killer cells therapy and Herceptin in patients with HER2-overexpressing recurrent breast cancer.
Liang S; Niu L; Xu K; Wang X; Liang Y; Zhang M; Chen J; Lin M
Mol Immunol; 2017 Dec; 92():45-53. PubMed ID: 29040918
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous cryoablation of renal cell carcinoma guided by horizontal open magnetic resonance imaging.
Miki K; Shimomura T; Yamada H; Kishimoto K; Ohishi Y; Harada J; Egawa S
Int J Urol; 2006 Jul; 13(7):880-4. PubMed ID: 16882047
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous Cryoablation of Clinical T2 (> 7 cm) Renal Masses: Technical Considerations, Complications, and Short-Term Outcomes.
Moynagh MR; Schmit GD; Thompson RH; Boorjian SA; Woodrum DA; Curry TB; Atwell TD
J Vasc Interv Radiol; 2015 Jun; 26(6):800-6. PubMed ID: 25840835
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte therapy of renal cell carcinoma.
Dillman RO
Expert Rev Anticancer Ther; 2005 Dec; 5(6):1041-51. PubMed ID: 16336095
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of percutaneous cryoablation for stage 1A/B renal cell carcinoma: results of a prospective, single-arm, 5-year study.
Georgiades CS; Rodriguez R
Cardiovasc Intervent Radiol; 2014 Dec; 37(6):1494-9. PubMed ID: 24385225
[TBL] [Abstract][Full Text] [Related]
18. Safety and Short-Term Efficacy of Irreversible Electroporation and Allogenic Natural Killer Cell Immunotherapy Combination in the Treatment of Patients with Unresectable Primary Liver Cancer.
Yang Y; Qin Z; Du D; Wu Y; Qiu S; Mu F; Xu K; Chen J
Cardiovasc Intervent Radiol; 2019 Jan; 42(1):48-59. PubMed ID: 30151798
[TBL] [Abstract][Full Text] [Related]
19. [Zeta chain level of T and NK cells in patients with renal-cell carcinoma and bladder cancer and its clinical significance].
Han Y; Li CL; Lu L; Zhou CX; Ma WB; Wang DM; Zhang SR
Zhonghua Zhong Liu Za Zhi; 2004 Mar; 26(3):158-60. PubMed ID: 15196436
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of CT-guided percutaneous cryoablation for renal cell carcinoma.
Georgiades CS; Hong K; Bizzell C; Geschwind JF; Rodriguez R
J Vasc Interv Radiol; 2008 Sep; 19(9):1302-10. PubMed ID: 18725093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]